May 03, 2005
Bio Ventures for Global Health (BVGH) aims to accelerate the development, distribution and accessibility of biotechnology products that address diseases of the developing world. BVGH seeks to break traditional barriers to development, bridging the gap between biotechnology's immense promise and the enormous unmet health needs of the developing world. BVGH has published a response to the advance market commitment report. They say:
BIO Ventures for Global Health enthusiastically supports the Advance Market Commitment concept. Our aim is to ensure that AMC programs are implemented in a way that is both cost effective for sponsors and attractive to industry's most capable innovators to invest in -- and accelerate the development of -- innovative products for the developing world.
CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.